tert-Butyl 4-(2-ethoxy-2-oxoethoxy)piperidine-1-carboxylate

Catalog No.: 
ACFLOO586
CAS No.: 
189889-45-0
Molecular Formula: 
C14H25NO5
Molecular Weight: 
287.36
tert-Butyl 4-(2-ethoxy-2-oxoethoxy)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$330.00InquiryInquiry
1g97%$420.00InquiryInquiry
5g97%$1141.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(2-ethoxy-2-oxoethoxy)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-(2-ethoxy-2-oxoethoxy)piperidine-1-carboxylate
MDL No.MFCD06858765
Molecular FormulaC14H25NO5
Molecular Weight287.36
SMILESO=C(COC1CCN(C(OC(C)(C)C)=O)CC1)OCC
InChI KeyBTANMNWDTQXBSP-UHFFFAOYSA-N
Synonymtert-butyl 4-(2-ethoxy-2-oxoethoxy)piperidine-1-carboxylate;1-BOC-4-ETHOXYCARBONYLMETHOXYPIPERIDINE;1-Piperidinecarboxylic acid, 4-(2-ethoxy-2-oxoethoxy)-, 1,1-dimethylethyl ester;Ethyl 2-[(1-Boc-piperidin-4-yl)oxy]acetate
CAS No.189889-45-0

Synthetic Route by SureRoute

1. ACFLOO586 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFLOO586 route product structure diagram
    ACFLOO586189889-45-0
Inquiry

2. ACFLOO586 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFLOO586 route product structure diagram
    ACFLOO586189889-45-0
Inquiry

3. ACFLOO586 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFLOO586 route product structure diagram
    ACFLOO586189889-45-0
Inquiry

Comments (0)